BNTX - BioNTech SE
NasdaqGS - NasdaqGS Real-time price. Currency in USD
33.44
+2.84 (+9.28%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
| Previous close | 30.60 |
| Open | 30.00 |
| Bid | 0.00 x 3200 |
| Ask | 0.00 x 1400 |
| Day's range | 30.00 - 33.96 |
| 52-week range | 12.52 - 48.85 |
| Volume | 201,464 |
| Avg. volume | 221,054 |
| Market cap | 7.584B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 13 Nov 2019 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 28.25 |
- Zacks
Biotech Stock Roundup: Updates From HZNP & CLVS, BioNTech to Acquire Neon
A low-key week for the biotech sector with a few pipeline and regulatory updates.
- Reuters
European biotech firm BioNTech reverses course in early trading
Shares of BioNTech SE tumbled nearly 12% in afternoon trade, erasing all its gains from earlier on Thursday, another sign of weakness in the IPO market after the collapse of WeWork's market debut. The shares backpedalled even though the German biotech firm downsized its initial public offering (IPO) and priced its stock below an earlier expected range on Wednesday. A bout of stock market volatility fuelled by worries over the potential economic impact of a trade war between the United States and China has led to IPO hopefuls delaying their listings or shares of those recently listed floundering.
